Search Results - "Edmonson, Shyrie"
-
1
Assessing the potential for AAV vector genotoxicity in a murine model
Published in Blood (24-03-2011)“…Gene transfer using adeno-associated virus (AAV) vectors has great potential for treating human disease. Recently, questions have arisen about the safety of…”
Get full text
Journal Article -
2
AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Published in Blood (03-09-2009)“…In a clinical trial for adeno-associated virus serotype 1 (AAV-1)–mediated gene transfer to muscle for lipoprotein lipase (LPL) deficiency, 1 subject from the…”
Get full text
Journal Article -
3
Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B
Published in Molecular therapy (01-07-2012)“…Liver gene transfer for hemophilia B has shown very promising results in recent clinical studies. A potential complication of gene-based treatments for…”
Get full text
Journal Article -
4
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Published in Blood (01-10-2007)“…Adeno-associated virus (AAV)–mediated gene transfer of factor IX (F.IX) to the liver results in long-term expression of transgene in experimental animals, but…”
Get full text
Journal Article -
5
Diverse IgG subclass responses to adeno-associated virus infection and vector administration
Published in Journal of medical virology (01-01-2009)“…Humoral immune responses occur following exposure to Adeno-associated virus (AAV) or AAV vectors. Many studies characterized antibody responses to AAV, but…”
Get full text
Journal Article -
6
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
Published in Molecular therapy. Methods & clinical development (01-01-2015)“…Adeno-associated virus (AAV) has become one of the most promising vectors in gene transfer in the last 10 years with successful translation to clinical trials…”
Get full text
Journal Article -
7
Persistent Expression of hF.IX After Tolerance Induction by In Utero or Neonatal Administration of AAV-1-F.IX in Hemophilia B Mice
Published in Molecular therapy (01-09-2007)“…The major complication associated with protein replacement therapy currently used in the treatment of hemophilia B (HB) is the development of antibodies to the…”
Get full text
Journal Article -
8
Pre-existing AAV Capsid-specific CD8+ T Cells are Unable to Eliminate AAV-transduced Hepatocytes
Published in Molecular therapy (01-04-2007)“…The goal of these studies was to test whether adeno-associated virus (AAV) capsid-specific CD8+ T cells cause loss of hepatic AAV-mediated gene expression in…”
Get full text
Journal Article -
9
High-throughput Screening and Biophysical Interrogation of Hepatotropic AAV
Published in Molecular therapy (01-12-2008)“…We set out to analyze the fundamental biological differences between AAV2 and AAV8 that may contribute to their different performances in vivo. High-throughput…”
Get full text
Journal Article -
10
Assessment of Insertional Mutagenesis Risk Following AAV Vector-Mediated Factor IX Gene Transfer in Mice
Published in Blood (20-11-2009)“…Abstract 2465 Poster Board II-442 Gene therapy for Hemophilia B is a promising alternative to recombinant protein therapy. Long-term expression of coagulation…”
Get full text
Journal Article -
11
Immunosuppression Modulates Immune Responses to AAV Capsid in Human Subjects Undergoing Intramuscular Gene Transfer for Lipoprotein Lipase Deficiency
Published in Blood (16-11-2008)“…Administration of adeno-associated viral vectors (AAV) has resulted in long-term therapeutic gene transfer in multiple large animal models of disease, but…”
Get full text
Journal Article -
12
Conserved Amino Acid Sequences in Parvovirus B19 and Adeno-Associated Virus Stimulate Functionally Cross-Reactive CD8 T Cells
Published in Blood (16-11-2006)“…Use of adeno-associated virus (AAV) to achieve liver-targeted gene transfer for the treatment of hemophilia B in human subjects resulted in the expression of…”
Get full text
Journal Article -
13
74. Cellular Immunity to Adeno-Associated Virus Capsid Attenuates Transgene Expression in the Liver
Published in Molecular therapy (01-05-2006)“…Adeno-associated virus (AAV) vectors hold the potential to treat a variety of inherited and acquired human diseases. One of the confounding issues regarding…”
Get full text
Journal Article -
14
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene
Published in Blood (01-11-2004)“…Animal models have been critical to the development of novel therapeutics in hemophilia. A deficiency of current murine models of hemophilia B is that they are…”
Get full text
Journal Article -
15
The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors
Published in Molecular therapy (01-01-2006)“…Identifying factors that influence gene transfer efficacy is critical for a successful gene-based clinical study. Here we demonstrate that in vivo…”
Get full text
Journal Article -
16
A Novel Role of Coagulation Proteases on Viral-Based Gene Transfer Efficacy
Published in Blood (16-11-2004)“…Coagulation proteases are crucial for hemostasis and have also been implicated in inflammatory responses, blood vessel formation, and tumor cell metastasis…”
Get full text
Journal Article -
17
37. Duration of Immunologically Detectable AAV-2 Capsid in an Animal Model
Published in Molecular therapy (01-05-2004)“…In a Phase I trial for Hemophilia B six subjects underwent infusion of an adeno-associated viral (AAV) vector expressing human Factor IX (F.IX) under the…”
Get full text
Journal Article